Scarica l'app Stockscreener
0.00
100.00%
-7.59
Trxade Health Inc Borsa (MEDS) Ultime notizie
TRxADE HEALTH (NASDAQ:MEDS) Trading Down 7% – What’s Next? - Defense World
TRxADE HEALTH (NASDAQ:MEDS) Stock Price Down 7% – What’s Next? - Defense World
TRxADE HEALTH (NASDAQ:MEDS) Trading 2.8% Higher – What’s Next? - Defense World
Scienture Holdings to Present at Microcap Conference 2025: Strategic Growth Plans in Focus - StockTitan
Trxade Group, Inc. Reports Earnings Results for the Second Quarter Ended June 30, 2019 - Marketscreener.com
Trxade Group, Inc. acquired Community Specialty Pharmacy, LLC from Nikul Panchal for $0.6 million. - Marketscreener.com
Scienture Secures Crucial Patent Protection for Novel Losartan Oral Suspension Through 2041 - StockTitan
Scienture Holdings, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2024 - Marketscreener.com
(SCNX) On The My Stocks Page - Stock Traders Daily
Gajan A. Mahendiran and Amudha Mahendiran acquired Westminster Pharmaceutical LLC from Trxade Group, Inc. for $1.6 million. - Marketscreener.com
Scienture Holdings Unveils New Identity Post-Merger - TipRanks
TRxADE Health changes its name to Scienture Holdings - AlphaStreet
TRxADE Health, Inc. Announces Name Change to Scienture Holdings, Inc. and Ticker Symbol Change to “SCNX” - ForexTV.com
TRxADE Health rebrands as Scienture Holdings with new ticker SCNX - Investing.com
TRxADE Health, Inc. Announces Name Change to Scienture Holdings, Inc. - ForexTV.com
Trxade Health announces name change to Scienture Holdings - TipRanks
Long Term Trading Analysis for (MEDS) - Stock Traders Daily
Trxade Health (MEDS) Q2 2024 Research Summary - AlphaStreet
Trxade Health appoints Mani as President, Hariharan as CEO of Scienture - TipRanks
MEDS Earnings: A snapshot of Trxade’s Q2 2024 results - AlphaStreet
Virtu Financial LLC Buys New Shares in TRxADE HEALTH, Inc. (NASDAQ:MEDS) - Defense World
When the Price of (MEDS) Talks, People Listen - Stock Traders Daily
TRxADE Health, Inc. Announces New Addition and Changes to Scienture, LLC’s Executive Leadership Team - StockTitan
Trxade Group’s Strategic Merger and Rebranding as Scienture Holdings - TipRanks
Closing Figures: Trxade Health Inc (MEDS)’s Positive Finish at 12.79, Up 9.97 - The Dwinnex
Company’s Banking Shares: Up -53.93% from 52-Week Low, But Can the Momentum Hold? - The InvestChronicle
How To Trade (MEDS) - Stock Traders Daily
Surge In TRxADE (MEDS) Shares Following Business Combination Announcement - News IMC
Trxade Health closes business combination with Scienture in $103Mln deal - AlphaStreet
TRxADE Shares Surge on Scienture Merger - MarketWatch
$103M all-stock transaction merges TRxADE and Scienture, forming new company - Investing.com
TRxADE Health Merges with Scienture in $103M Deal - MarketWatch
TRxADE Health, Inc. Announces Business Combination with Scienture, Inc., in a Transaction Valued at $103 Million - ForexTV.com
Key Inflation data, 3M reports, and Bristol Myers report: Yahoo Finance - Head Topics
Trxade Health acquires Scienture in all-stock transaction valued at $103M - TipRanks
Tampa pharma company stacked with former McKesson execs launches IPO - The Business Journals
Trxade Health announces special cash dividend of $1.50 per share - TipRanks
TRxADE HEALTH, Inc. (MEDS) To Go Ex-Dividend on July 19th - Defense World
Janney Montgomery Scott LLC Purchases 10,099 Shares of AppLovin Co. (NASDAQ:APP) - Defense World
Shopify (TSE:SHO) Lifted to “Strong-Buy” at Wolfe Research - Defense World
(MEDS) Trading Report - Stock Traders Daily
TRxADE Health, Inc. Announces Special Cash Dividend - StockTitan
LVW Advisors LLC Has $458,000 Position in Best Buy Co., Inc. (NYSE:BBY) - Defense World
MEDS Earnings: Highlights of Trxade Health’s Q1 2024 financial results - AlphaStreet
TRxADE Health, Inc. Files its Q1 10-Q; Reporting Positive Net Income Due to Asset Sale - StockTitan
MEDS Stock Earnings: Trxade Health Reported Results for Q1 2024 - InvestorPlace
TRxADE Health appoints new board member Subbarao Jayanthi - Investing.com
Trxade Health Inc. (NASDAQ: MEDS) Q1 2024 Research Summary - AlphaStreet
PACS Group gears up for $400 million IPO. Here’s all you need to know - AlphaStreet
Femasys is committed to providing women with revolutionary healthcare products: CEO - AlphaStreet
Why Mesoblast Shares Are Trading Higher By 13%? Here Are Other Stocks Moving In Monday's Mid-Day Session - Benzinga
Trxade Health, Inc. Announces Special Cash Dividend, Payable on or About March 22, 2024 - Marketscreener.com
Why Is Trxade Health (MEDS) Stock Up 230% Today? - InvestorPlace
Trxade Group Divests Assets, Refocuses Pharmaceutical Strategy - TipRanks
Trxade Health Inc. (NASDAQ: MEDS) Q4 2023 Research Summary - AlphaStreet
VEEV: Medical Stock Trio: Buy, Hold, or Sell? - StockNews.com
MEDS Earnings: A snapshot of Trxade Health’s Q3 2023 financial results - AlphaStreet
TRxADE: Q3 Earnings Snapshot - Marketscreener.com
TRxADE Announces Receipt of Notification of Deficiency from Nasdaq Regarding Requirement to Timely File Quarterly Report on Form 10-Q. - StockTitan
Food technology company prepares to enter plant-based pet nutrition market - Pet Food Processing
0.52%
0.00%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):